Cigna-Express Scripts Deal Gets the Green Light

Cigna’s acquisition of Express Scripts was approved by federal officials
By Katie King Posted on September 20, 2018

Cigna’s $67 billion acquisition of pharmacy benefits manager (PBM), Express Scripts, was approved by federal officials this week.

The Council Perspective: Express Scripts is one of the last standalone PBMs. This, and other pending mergers like CVS Health and Aetna, signals a desire to lower costs and prevent any disturbance from startups and new industry players, like the recent Amazon Berkshire Hathaway JP Morgan venture. At the same time, PBMs have been criticized for their role in negotiating drug prices, leaving many questioning if mergers like this will help or hinder efforts to align incentives throughout the drug supply chain to reduce costs for end payers. To succeed, the new Cigna-Express Scripts will mostly likely need to think about its PBM arm as a value-focused component of its insurance business.

Katie King Vice President, Health Policy & Strategy, The Council Read More

More in Health+Benefits

Whether You See It or Not
Health+Benefits Whether You See It or Not
If you think you’re not employing people with substance use disorder, you’re...
Health+Benefits Insurer Bets on Transparency
Q&A with Shawn Wagoner, Co-Founder and Chief Revenue Officer, Surest, a business...
Brokers Deploy New Pharmacy Strategies
Health+Benefits Brokers Deploy New Pharmacy Strategies
Adapting to the changing pharmacy benefits space requires new expertise in a com...